Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Takashi Kida, Atsushi Umemura, Shunya Kaneshita, Risa Sagawa, Takuya Inoue, Shogo Toyama, Makoto Wada, Masataka Kohno, Ryo Oda, Tohru Inaba, Yoshito Itoh & Yutaka Kawahito. (2020) Effectiveness and safety of chronic hepatitis C treatment with direct-acting antivirals in patients with rheumatic diseases: A case-series. Modern Rheumatology 30:6, pages 1009-1015.
Read now
Read now
Dorota Zarębska-Michaluk, Robert Flisiak & Marta Flisiak-Jackiewicz. (2020) Management of hepatitis B and hepatitis C coinfection: an expert review. Expert Review of Anti-infective Therapy 18:10, pages 1033-1044.
Read now
Read now
Articles from other publishers (37)
El-Araby Mohamed Ibrahim Shalaby, Eman Abdelsameea, Mary Naguib, Asmaa Gomaa & Imam Waked. (2023) Outcome of direct-acting antiviral treatment in patients with hepatitis C virus/hepatitis B virus coinfection. Egyptian Liver Journal 13:1.
Crossref
Crossref
Olga V. Masalova, Ekaterina I. Lesnova, Sergey M. Andreev, Nadezhda N. Shershakova, Vyacheslav V. Kozlov, Kristina Yu. Permyakova, Natalia A. Demidova, Vladimir T. Valuev-Elliston, Evgeny A. Turetskiy, Alexander V. Ivanov, Tatyana N. Nikolaeva, Musa R. Khaitov, Alexander V. Pronin & Alla A. Kushch. (2023) Adjuvant effect of dispersed fullerene C60 on the immune response to constructs harboring amino acid and nucleotide sequences of hepatitis C virus nonstructural NS5B protein. Problems of Virology 67:6, pages 516-526.
Crossref
Crossref
Joo Hyun Oh, Dong Ah Park, Min Jung Ko, Jeong-Ju Yoo, Sun Young Yim, Ji-Hyun Ahn, Dae Won Jun & Sang Bong Ahn. (2022) Direct-Acting Antivirals and the Risk of Hepatitis B Reactivation in Hepatitis B and C Co-Infected Patients: A Systematic Review and Meta-Analysis. Journal of Personalized Medicine 12:12, pages 1957.
Crossref
Crossref
Anand V Kulkarni & Nageshwar Reddy Duvvuru. (2021) Management of hepatitis B and C in special population. World Journal of Gastroenterology 27:40, pages 6861-6873.
Crossref
Crossref
Yasunao Numata, Shigeru Sasaki, Noriyuki Akutsu, Takehiro Hirano, Kohei Wagatsuma, Yujiro Kawakami, Keisuke Ishigami & Hiroshi Nakase. (2021) A case of hepatitis B virus and hepatitis C virus co-infection that achieved sustained virological response 12 following treatment with glecaprevir hydrate/pibrentasvir for 3 daysグレカプレビル水和物・ピブレンタスビル配合剤の3日間投与で持続的ウイルス学的著効を達成したHBV・HCV共感染の一例. Kanzo 62:9, pages 578-584.
Crossref
Crossref
Galal Yahya, Nashwa Hashem Mohamed, Jordi Pijuan, Noura M. Seleem, Rasha Mosbah, Steffen Hess, Ahmed A. Abdelmoaty, Rafa Almeer, Mohamed M. Abdel‐Daim, Hamoud Shulaywih Alshaman, Ibrahim Juraiby, Kamel Metwally & Zuzana Storchova. (2021) Profiling the physiological pitfalls of anti‐hepatitis C direct‐acting agents in budding yeast. Microbial Biotechnology 14:5, pages 2199-2213.
Crossref
Crossref
Óscar Brochado-Kith, Isidoro Martínez, Juan Berenguer, Juan González-García, Sergio Salgüero, Daniel Sepúlveda-Crespo, Cristina Díez, Víctor Hontañón, Luis Ibañez-Samaniego, Leire Pérez-Latorre, Amanda Fernández-Rodríguez, María Ángeles Jiménez-Sousa & Salvador Resino. (2021) HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients. Frontiers in Immunology 12.
Crossref
Crossref
Ekaterina I. Lesnova, Olga V. Masalova, Kristina Yu. Permyakova, Vyacheslav V. Kozlov, Tatyana N. Nikolaeva, Alexander V. Pronin, Vladimir T. Valuev-Elliston, Alexander V. Ivanov & Alla A. Kushch. (2021) Difluoromethylornithine (DFMO), an Inhibitor of Polyamine Biosynthesis, and Antioxidant N-Acetylcysteine Potentiate Immune Response in Mice to the Recombinant Hepatitis C Virus NS5B Protein. International Journal of Molecular Sciences 22:13, pages 6892.
Crossref
Crossref
Yongzhen Liu, Stephanie Maya & Alexander Ploss. (2021) Animal Models of Hepatitis B Virus Infection–Success, Challenges, and Future Directions. Viruses 13:5, pages 777.
Crossref
Crossref
Ming-Ying Lu, Chun-Ting Chen, Yu-Lueng Shih, Pei-Chien Tsai, Meng-Hsuan Hsieh, Chung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, Shu-Chi Wang, Yi-Shan Tsai, Yu-Min Ko, Ching-Chih Lin, Kuan-Yu Chen, Yu-Ju Wei, Po-Yao Hsu, Cheng-Ting Hsu, Tyng-Yuan Jang, Ta-Wei Liu, Po-Cheng Liang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu & Wen-Yu Chang. (2021) Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan. Scientific Reports 11:1.
Crossref
Crossref
Shiva Poola, Sirish Sanaka, Kerry Sewell & Hans L. Tillmann. (2020) Hepatitis B surface antibody titres and hepatitis B reactivation with direct‐acting antiviral therapy for hepatitis C. Journal of Viral Hepatitis 28:2, pages 373-382.
Crossref
Crossref
Po-Cheng Liang, Kuan-Yu Chen, Chung-Hao Huang, Ko Chang, Po-Liang Lu, Ming-Lun Yeh, Chung-Feng Huang, Ching-I Huang, Meng-Hsuan Hsieh, Chia-Yen Dai, Zu-Yau Lin, Shinn-Chern Chen, Wan-Long Chuang, Yen-Hsu Chen, Jee-Fu Huang & Ming-Lung Yu. (2020) Viral Interference Between Dengue Virus and Hepatitis C Virus Infections. Open Forum Infectious Diseases 7:8.
Crossref
Crossref
Debra Guss, Jagannath Sherigar & Smruti R. Mohanty. (2020) Management of Hepatitis C. Gastroenterology Nursing 43:1, pages 22-27.
Crossref
Crossref
Bonolo Bonita Phinius, Motswedi Anderson, Resego Bokete, Tshepiso Mbangiwa, Wonderful Tatenda Choga, Kabo Baruti, Joseph Makhema, Rosemary Musonda, Jason T. Blackard, Max Essex, Sikhulile Moyo, Richard Marlink & Simani Gaseitsiwe. (2020) Incidence of hepatitis B virus infection among human immunodeficiency virus-infected treatment naïve adults in Botswana. Medicine 99:9, pages e19341.
Crossref
Crossref
Yachao Tao, Dongbo Wu, Lingyun Zhou, Enqiang Chen, Changhai Liu, Xiaoqiong Tang, Wei Jiang, Ning Han, Hong Li & Hong Tang. 2020. Hepatitis B Virus Infection. Hepatitis B Virus Infection
137
186
.
Noha H. Habashy & Marwa M. Abu-Serie. (2019) Major royal-jelly protein 2 and its isoform X1 are two novel safe inhibitors for hepatitis C and B viral entry and replication. International Journal of Biological Macromolecules 141, pages 1072-1087.
Crossref
Crossref
Tatsuo Kanda, George K. K. Lau, Lai Wei, Mitsuhiko Moriyama, Ming-Lung Yu, Wang-Long Chuang, Alaaeldin Ibrahim, Cosmas Rinaldi Adithya Lesmana, Jose Sollano, Manoj Kumar, Ankur Jindal, Barjesh Chander Sharma, Saeed S. Hamid, A. Kadir Dokmeci, Mamun-Al-Mahtab, Geoffrey W. McCaughan, Jafri Wasim, Darrell H. G. Crawford, Jia-Horng Kao, Yoshihiko Ooka, Osamu Yokosuka, Shiv Kumar Sarin & Masao Omata. (2019) APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation. Hepatology International 13:6, pages 649-661.
Crossref
Crossref
Arnaud Del Bello, Florence Abravanel, Laurent Alric, Laurence Lavayssiere, Sébastien Lhomme, Julie Bellière, Jacques Izopet & Nassim Kamar. (2019) No evidence of occult hepatitis C or E virus infections in liver‐transplant patients with sustained virological response after therapy with direct acting agents. Transplant Infectious Disease 21:4.
Crossref
Crossref
Ming-Lun Yeh, Ching-I Huang, Chung-Feng Huang, Meng-Hsuan Hsieh, Ta-Wei Liu, Yi-Hung Lin, Po-Cheng Liang, Ming-Yen Hsieh, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Po-Lin Kuo, Chia-Yen Dai, Ming-Lung Yu & Wan-Long Chuang. (2019) Pretreatment Hepatitis B Viral Load Predicts Long-Term Hepatitis B Response After Anti-Hepatitis C Therapy in Hepatitis B/C Dual-Infected Patients. The Journal of Infectious Diseases 219:8, pages 1224-1233.
Crossref
Crossref
Cristina Musolino, Irene Cacciola, Gianluca Tripodi, Daniele Lombardo, Giuseppina Raffa, Angela Alibrandi, Giovanni Squadrito, Giovanni Raimondo & Teresa Pollicino. (2018) Behaviour of Occult HBV Infection in HCV-Infected Patients under Treatment with Direct-Acting Antivirals. Antiviral Therapy 24:3, pages 187-192.
Crossref
Crossref
Maria Laura Ponti, Federica Comitini, Debora Murgia, Roberto Ganga, Roberto Canu, Carlo Dessì, Maria Loreta Foschini, GianBattista Leoni, Maddalena Morittu, Maria Perra, Maria Paola Pilia, Maria Rosaria Casini, Antonietta Zappu & Raffaella Origa. (2019) Impact of the direct-acting antiviral agents (DAAs) on chronic hepatitis C in Sardinian patients with transfusion-dependent Thalassemia major. Digestive and Liver Disease 51:4, pages 561-567.
Crossref
Crossref
Jacinta A. Holmes, Charles Carlton-Smith, Arthur Y. Kim, Emily O. Dumas, Joelle Brown, Jenna L. Gustafson, Georg M. Lauer, Sakuni T. Silva, Maxwell Robidoux, Daniel Kvistad, Nadia Alatrakchi, Pierre Tonnerre, Daniel E. Cohen, Hongtao Zhang, Nancy S. Shulman & Raymond T. Chung. (2019) Dynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infection. Journal of Viral Hepatitis 26:3, pages 362-372.
Crossref
Crossref
A. Prenner, R. Blum, H. Beltraminelli, G. Stirnimann & L. Borradori. (2018) Subacute cutaneous lupus erythematosus triggered by an antiviral treatment combination for hepatitis C virus infection. Journal of the European Academy of Dermatology and Venereology 33:3.
Crossref
Crossref
Xiao Liu, Xiaoqiong Duan, Jacinta A. Holmes, Wenting Li, Sae Hwan Lee, Zeng Tu, Chuanlong Zhu, Shadi Salloum, Anna Lidofsky, Esperance A. Schaefer, Dachuan Cai, Shilin Li, Haoju Wang, Yongfu Huang, Yongju Zhao, Ming‐Lung Yu, Zhiwen Xu, Limin Chen, Jian Hong, Wenyu Lin & Raymond T. Chung. (2019) A Long Noncoding RNA Regulates Hepatitis C Virus Infection Through Interferon Alpha–Inducible Protein 6. Hepatology 69:3, pages 1004-1019.
Crossref
Crossref
Jing Wang, Chunhua Hu, Yi Chen, Zhengwen Liu, Qiang Yu, Shujuan Yang, Jun Dong, Yuan Yang, Yuchao Wu, Danfeng Ren, Naijuan Yao, Dandan Guo, Zhen Tian, Yingren Zhao, Tianyan Chen, Yingli He & Jinfeng Liu. (2018) HBV Reactivation during Direct-Acting Antiviral Therapy in Hepatitis B and C Coinfected Patients Undergoing Haemodialysis. Antiviral Therapy 24:2, pages 77-84.
Crossref
Crossref
Alfredo Marzano, Emanuele Angelucci, Marco Astegiano, Chiara Baratelli, Luigi Biancone, Paolo Bironzo, Giuseppina Brancaccio, Maurizia Rossana Brunetto, Raffaele Bruno, Patrizia Burra, Maria Giuseppina Cabras, Paolo Caraceni, Claudia Chialà, Maria Grazia Clemente, Agostino Colli, Bruno Daniele, Elisabetta De Gasperi, Vito Di Marco, Maria Chiara Ditto, Stefano Fagiuoli, Clodoveo Ferri, Giovanni Battista Gaeta, Paolo Antonio Grossi, Barbara Imperatrice, Pietro Lampertico, Fabio Salvatore Macaluso, Salvatore Madonia, Massimo Marignani, Chiara Mazzarelli, Alberto Mella, Gabriele Missale, Simone Parisi, Luisa Pasulo, Massimo Puoti, Maria Rendina, Davide Ribaldone, Giuseppe Rossi, Pierluigi Toniutto, Alessandra Tucci, Pietro Vajro, Mauro Viganò, Riccardo Volpes & Anna Linda Zignego. (2019) AISF position paper on HCV in immunocompromised patients. Digestive and Liver Disease 51:1, pages 10-23.
Crossref
Crossref
Niloofar Naderi, Ghazal Masoudi, Bita Behnava, Seyed Moayed Alavian, Soyar Sari, Ali Anvar, Alireza Azizi Saraji, Ali Namvar & Azam Bolhassani. (2018) Detection of Occult Hepatitis B Virus Among Iranian HCV-Infected Patients with Hemophilia Treated with Direct-Acting Antiviral Agents. Hepatitis Monthly In Press:In Press.
Crossref
Crossref
Chung-Feng Huang, Ming-Lun Yeh, Ching-I Huang, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Jyh-Jou Chen & Ming-Lung Yu. (2018) Tolloid-like 1 genetic variants determine fibrosis regression in chronic hepatitis C patients with curative antivirals. Scientific Reports 8:1.
Crossref
Crossref
Marianna G. Mavilia & George Y. Wu. (2018) HBV-HCV Coinfection: Viral Interactions, Management, and Viral Reactivation. Journal of Clinical and Translational Hepatology 6:3, pages 1-10.
Crossref
Crossref
Meng-Hsuan Hsieh & Ming-Lung Yu. (2018) Reply to “Rescue for interferon failures in HCV genotype 1/HBV dually infection”. Journal of the Formosan Medical Association 117:9, pages 861-862.
Crossref
Crossref
C. M. Preda, C. P. Popescu, C. Baicus, I. Constantinescu, A. Oproiu, T. Voiosu, M. Diculescu, L. Negreanu, L. Gheorghe, I. Sporea, A. Trifan, E. Ceausu, D. Proca & M. Manuc. (2018) Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin. Journal of Viral Hepatitis 25:7, pages 834-841.
Crossref
Crossref
Alessandra Tucci, Stefano Rizza, Donatella Cocchis, Silvia Martini, Renato Romagnoli & Alfredo Marzano. (2018) Early and Late Hepatitis B Reactivation After IFN- or DAA-based Therapy of Recurrent Hepatitis C in Anti–HBc-positive Liver Transplant Recipients. Transplantation 102:7, pages e354-e355.
Crossref
Crossref
Qi Wu, Zhubing Li & Qiang Liu. (2018) An important role of SREBP-1 in HBV and HCV co-replication inhibition by PTEN. Virology 520, pages 94-102.
Crossref
Crossref
Debra Guss, Jagannath Sherigar, Paul Rosen & Smruti R. Mohanty. (2018) Diagnosis and Management of Hepatitis C Infection in Primary Care Settings. Journal of General Internal Medicine 33:4, pages 551-557.
Crossref
Crossref
Ralf Bartenschlager, Thomas F. Baumert, Jens Bukh, Michael Houghton, Stanley M. Lemon, Brett D. Lindenbach, Volker Lohmann, Darius Moradpour, Thomas Pietschmann, Charles M. Rice, Robert Thimme & Takaji Wakita. (2018) Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies. Virus Research 248, pages 53-62.
Crossref
Crossref
Tatsuo Kanda, Shin Yasui, Masato Nakamura, Shingo Nakamoto, Koji Takahashi, Shuang Wu, Reina Sasaki, Yuki Haga, Sadahisa Ogasawara, Tomoko Saito, Kazufumi Kobayashi, Soichiro Kiyono, Yoshihiko Ooka, Eiichiro Suzuki, Tetsuhiro Chiba, Hitoshi Maruyama, Fumio Imazeki, Mitsuhiko Moriyama & Naoya Kato. (2018) Interferon-free treatment for patients with chronic hepatitis C and autoimmune liver disease: higher SVR rates with special precautions for deterioration of autoimmune hepatitis. Oncotarget 9:14, pages 11631-11637.
Crossref
Crossref
Tatsuo Kanda, Kazushige Nirei, Naoki Matsumoto, Teruhisa Higuchi, Hitomi Nakamura, Hiroaki Yamagami, Shunichi Matsuoka & Mitsuhiko Moriyama. (2017) Retreatment of patients with treatment failure of direct-acting antivirals: Focus on hepatitis C virus genotype 1b. World Journal of Gastroenterology 23:46, pages 8120-8127.
Crossref
Crossref